Citigroup Maintains Buy Rating on Roivant Sciences, Raises Target to $56
Citigroup raised its price target on Roivant Sciences to $56 per share from $46 while maintaining its Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.